- Anil Singhvi highlighted the company's strong brand value and reputed promoters, including Temasek, the investment company owned by the Government of Singapore.
- The company plans to use IPO proceeds for debt repayment, which could result in savings of around Rs 500 crore in interest expenses.
- Singhvi pointed out that around 46 per cent of Manipal Health Enterprises' revenue comes from Karnataka, but the company is expanding beyond its core market.
Manipal Health Enterprises is set to launch a ₹9,275 crore IPO from July 29 to July 31, 2026, as it aims to strengthen its market position.
Anil Singhvi noted the company's strong brand value and the backing of Temasek, the Singaporean investment firm, as key positives.123
The hospital chain, which operates 49 hospitals with over 13,000 licensed beds, is a market leader in bed capacity. Singhvi mentioned that approximately 46% of its revenue comes from Karnataka, but the company is expanding its footprint with plans to open two new hospitals in Mumbai.67
The IPO proceeds will be utilized for debt repayment, potentially saving around ₹500 crore in interest expenses. Singhvi also pointed out that the company posted a 25.4% year-on-year revenue growth to ₹10,335 crore in FY26, outperforming competitors like Apollo Hospitals and Max Healthcare.45
The IPO price band is set between ₹560 and ₹590 per share, with a minimum application lot size of 25 shares.
With a P/E ratio of 76.5x, Manipal Health leads the market, followed by Max Healthcare and Apollo Hospitals.
This IPO is expected to enhance the company's financial stability and market reach significantly.
“The company plans to use IPO proceeds for debt repayment, potentially saving around ₹500 crore in interest expenses. Singhvi noted that while 46% of revenue comes from Karnataka, Manipal is expanding its footprint with plans to open two hospitals in Mumbai.”
Zee Business
